Comparison of culture and isolation methods for Clostridioides difficile and other anaerobes from stool samples in a routine microbiological laboratory practice

Comparison of culture and isolation methods for Clostridioides difficile and other anaerobes from stool samples in a routine microbiological laboratory practice

Objective. To improve stool sample culture and isolation of anaerobic flora, including Clostridioides difficile in the routine microbiological laboratory practice at the children’s oncology hospital. Materials and Methods. A total of 517 stool samples collected from patients in children’s oncolo...

Full description

Bibliographic Details
Main Authors:	Shvydkaya M.G., Zatevalov A.M., Mitrokhin S.D., Dzhandarova D.T.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2021-06-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	culture liquid medium stool samples clostridium difficile anaerobes
Online Access:	https://cmac-journal.ru/publication/2021/2/cmac-2021-t23-n2-p212/cmac-2021-t23-n2-p212.pdf

Similar Items

Family Stool Donation Predicts Failure of Fecal Microbiota Transplant for Clostridioides difficile Infection
by: Ariel E. Watts, et al.
Published: (2022-01-01)

Assessment of the Effect of Multidrug Resistance Clostridium difficile Clinical Strains on the Dynamics of Clostridium difficile Infection Rate at Pediatric Oncological Hospital
by: M. G. Shvydkaya, et al.
Published: (2021-03-01)

Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection
by: Ching-Chi Lee, et al.
Published: (2021-10-01)

Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
by: Justin Chen, et al.
Published: (2021-04-01)

Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
by: Louis-Charles Fortier
Published: (2018-08-01)

Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank
by: Madeleine Gill, et al.
Published: (2020-10-01)

Human and Porcine Transmission of Clostridioides difficile Ribotype 078, Europe
by: Geraldine Moloney, et al.
Published: (2021-09-01)

National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
by: Kristina Rizzardi, et al.
Published: (2018-09-01)

Stool cultures at the ICU: get rid of it!
by: Carolin F. Manthey, et al.
Published: (2018-01-01)

Editorial: The Deadly Secrets of C. difficile—Insights Into Host-Pathogen Interaction
by: Meina Neumann-Schaal, et al.
Published: (2022-04-01)

Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells
by: Adrianne N Edwards, et al.
Published: (2016-10-01)

Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration
by: Khadijah M. Alammari, et al.
Published: (2021-02-01)

Metabolic Reprogramming of Clostridioides difficile During the Stationary Phase With the Induction of Toxin Production
by: Julia D. Hofmann, et al.
Published: (2018-08-01)

Strain Variation in Clostridioides difficile Cytotoxicity Associated with Genomic Variation at Both Pathogenic and Nonpathogenic Loci
by: Katie Saund, et al.
Published: (2022-06-01)

c-di-GMP Inhibits Early Sporulation in Clostridioides difficile
by: Adrianne N. Edwards, et al.
Published: (2021-12-01)

<i>Clostridioides difficile</i> Infection, Still a Long Way to Go
by: Eleftheria Kampouri, et al.
Published: (2021-01-01)

<i>Clostridioides difficile</i>, a New “Superbug”
by: Rumyana Markovska, et al.
Published: (2023-03-01)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
by: Teena Chopra, et al.
Published: (2023-01-01)

Prevalence of and factors associated with inappropriate Clostridioides difficile testing in a teaching hospital in Korea
by: Hee Bum Jo, et al.
Published: (2022-05-01)

<i>Clostridioides difficile</i> – a new name, the old problems with diagnosis and treatment
by: Sergey M. Zakharenko
Published: (2023-01-01)

Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014–2019
by: Ahmed Mohamed Mostafa Abdrabou, et al.
Published: (2021-05-01)

Host and Clostridioides difficile-Response Modulated by Micronutrients and Glutamine: An Overview
by: Andréa V. Loureiro, et al.
Published: (2022-06-01)

Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective
by: Lucy Hocking, et al.
Published: (2023-01-01)

Clostridioides difficile 630Δerm in silico and in vivo – quantitative growth and extensive polysaccharide secretion
by: Henning Dannheim, et al.
Published: (2017-04-01)

Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile
by: Hamid Heidari, et al.
Published: (2019-07-01)

Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection
by: Vanessa Lang, et al.
Published: (2022-03-01)

Activity of omadacycline in vitro against Clostridioides difficile and preliminary efficacy assessment in a hamster model of C. difficile-associated diarrhoea
by: Raina Gay Leahy, et al.
Published: (2022-09-01)

Patient Experiences with Clostridioides difficile Infection: Results of a Canada-Wide Survey
by: Vent-Schmidt J, et al.
Published: (2020-01-01)

Comparison of commercial assays and two-step approach to detect Clostridioides difficile in South Africa
by: Sarishna Singh, et al.
Published: (2022-09-01)

The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity
by: Nicholas A. Lesniak, et al.
Published: (2022-08-01)

Epidemiology of Clostridioides difficile Infection in Portugal: A Retrospective, Observational Study of Hospitalized Patients
by: Cláudia Nazareth, et al.
Published: (2022-04-01)

Clostridium difficile – From Colonization to Infection
by: Holger Schäffler, et al.
Published: (2018-04-01)

Real-World Experience with Bezlotoxumab for Prevention of Recurrence of <em>Clostridioides difficile</em> Infection
by: Rosa Escudero-Sánchez, et al.
Published: (2020-12-01)

Trends in Clostridioides difficile prevalence, mortality, severity, and age composition during 2003–2014, the national inpatient sample database in the US
by: Sun O. Park, et al.
Published: (2022-12-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
by: Margherita Gnocchi, et al.
Published: (2020-04-01)

Vitamin D3 and carbamazepine protect against Clostridioides difficile infection in mice by restoring macrophage lysosome acidification
by: Chan, Hung, et al.
Published: (2022)

Characteristics, Risk Factors, and Prevalence of Clostridioides difficile Among Hospitalized Patients in a Tertiary Care Hospital in Palestine
by: Abukhalil AD, et al.
Published: (2021-11-01)

Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain
by: Andrew M. Skinner, et al.
Published: (2020-02-01)

Development of a Prediction Model to Identify the Risk of <i>Clostridioides difficile</i> Infection in Hospitalized Patients Receiving at Least One Dose of Antibiotics
by: Abdulrahman Alamri, et al.
Published: (2024-02-01)

Infección por clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticas
by: S. Lital Meyer, Dra., et al.
Published: (2014-05-01)